Skip to content
10-Q

Quarterly Report

Foamix Pharmaceuticals Ltd.

0001178913-19-002668

← back to feed
Filed
Nov 12, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 4, 2019 61.25M sh
Capex Q3 2019 · Sep 30, 2019 $861K
Capex Q3 2019 · Sep 30, 2018 $408K
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$51.15M
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$57.77M
Long Term Debt Q3 2019 · Sep 30, 2019 $12.94M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $40.53M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $27.87M
Cash And Equivalents Q3 2019 · Sep 30, 2018 $87.88M
Stockholders Equity Q3 2019 · Sep 30, 2019 $53.53M
Stockholders Equity Q3 2019 · Jun 30, 2019 $60.38M
Stockholders Equity Q3 2019 · Dec 31, 2018 $92.18M
Stockholders Equity Q3 2019 · Sep 30, 2018 $105.06M
Stockholders Equity Q3 2019 · Jun 30, 2018 $43.9M
Stockholders Equity Q3 2019 · Dec 31, 2017 $68.6M
Current Liabilities Q3 2019 · Sep 30, 2019 $13.37M
Current Liabilities Q3 2019 · Dec 31, 2018 $10.47M
Total Liabilities Q3 2019 · Sep 30, 2019 $28.05M
Total Liabilities Q3 2019 · Dec 31, 2018 $11.55M
Current Assets Q3 2019 · Sep 30, 2019 $76.53M
Current Assets Q3 2019 · Dec 31, 2018 $101.17M
Total Assets Q3 2019 · Sep 30, 2019 $81.58M
Total Assets Q3 2019 · Dec 31, 2018 $103.73M
Sga Expense Q3 2019 · Sep 30, 2019 $10.75M
Sga Expense Q3 2019 · Sep 30, 2019 $22.89M
Sga Expense Q3 2019 · Sep 30, 2018 $3.31M
Sga Expense Q3 2019 · Sep 30, 2018 $10.02M
Rd Expense Q3 2019 · Sep 30, 2019 $12.45M
Rd Expense Q3 2019 · Sep 30, 2019 $35.86M
Rd Expense Q3 2019 · Sep 30, 2018 $13.14M
Rd Expense Q3 2019 · Sep 30, 2018 $52.81M
Net Income Q3 2019 · Sep 30, 2019 −$23.16M
Net Income Q3 2019 · Sep 30, 2019 −$57.36M
Net Income Q3 2019 · Sep 30, 2018 −$15.48M
Net Income Q3 2019 · Sep 30, 2018 −$60.09M
Operating Income Q3 2019 · Sep 30, 2019 −$23.2M
Operating Income Q3 2019 · Sep 30, 2019 −$58.44M
Operating Income Q3 2019 · Sep 30, 2018 −$15.59M
Operating Income Q3 2019 · Sep 30, 2018 −$60.09M
Revenue Q3 2019 · Sep 30, 2019 $308K
Revenue Q3 2019 · Sep 30, 2018 $865K
Revenue Q3 2019 · Sep 30, 2018 $2.74M